Ethyl 2-allylamino-4-methyl-thiazole-5-carboxylate, 98.0%, 10g

4-(Bromomethyl)-2,6-dichloropyridine, 95.0%, 250mg

1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP) , 100mL, >=99%, for peptide synthesis

3-Acetyl-6-methoxyindole, 95.0%, 5g

1-(Diphenylmethyl)azetidine-3-carboxylic acid, 95.0%, 25g

2-Ethyl-2-hexenal, 95.0%, 10g

(2R,3S,4S,5S,6R)-2-(Hydroxymethyl)-6-(4-isothiocyanatophenoxy)tetrahydro-2H-pyran-3,4,5-triol, 97.0%, 250mg

2-CHLOROACETOHYDRAZIDE HCL, 97.0%, 250mg

cis-(1-Benzylazetidine-2,4-diyl)dimethanol, 95.0%, 5g

3-Bromothiophene-2-carboxaldehyde, 98.0%, 10g

2-(Propylamino)ethanol>98.0%(GC)(T)5g

28-(tert-butoxy)-1-(diazyn-1-ium-1-yl)-28-oxo-4,7,10,13,16,19,22,25-octaoxa-1-azaoctacosan-1-ide, 95%, 250mg

2-benzoyl-1-(4-methoxybenzyl)-1,2-dihydroisoquinoline-1-carbonitrile, 98%, 250mg